(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.
The three biggest winners today are ASETEK, EXMAR, and INNATE PHARMA.
| Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|
| ASETEK (ASTK.OL) | 6.90 | 24.77% | 2023-04-03 11:22:23 |
| EXMAR (EXM.BR) | 11.64 | 20% | 2023-04-03 11:08:26 |
| INNATE PHARMA (IPH.PA) | 3.08 | 14.75% | 2023-04-03 11:52:02 |
| DNO (DNO.OL) | 11.75 | 14.41% | 2023-04-03 11:23:48 |
| QUADIENT (QDT.PA) | 18.68 | 11.32% | 2023-04-03 11:01:56 |
| QUESTERRE ENERGY (QEC.OL) | 2.00 | 11.11% | 2023-04-03 11:33:16 |
| ARAMIS GROUP (ARAMI.PA) | 3.96 | 9.15% | 2023-04-03 11:38:23 |
| FINATIS (FNTS.PA) | 7.55 | 7.86% | 2023-04-03 08:50:31 |
| SEABIRD EXPLORAT (SBX.OL) | 4.58 | 7.14% | 2023-04-03 08:34:33 |
| FONCIERE 7 INVEST (LEBL.PA) | 0.94 | 6.82% | 2023-04-03 08:50:40 |
The three biggest losers today are SODITECH, CROSSWOOD, and ABIONYX PHARMA.
| Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|
| SODITECH (SEC.PA) | 1.42 | -17.44% | 2023-04-03 11:03:53 |
| CROSSWOOD (CROS.PA) | 7.05 | -11.87% | 2023-04-03 08:47:55 |
| ABIONYX PHARMA (ABNX.PA) | 2.09 | -8.55% | 2023-04-03 11:36:44 |
| OKEANIS ECO TANKER (OET.OL) | 237.00 | -7.96% | 2023-04-03 11:32:27 |
| AKVA GROUP (AKVA.OL) | 54.40 | -7.48% | 2023-04-03 11:22:05 |
| FRONTLINE (FRO.OL) | 159.56 | -6.81% | 2023-04-03 11:24:33 |
| ADUX (ADUX.PA) | 1.44 | -5.88% | 2023-04-03 08:37:44 |
| STOLT-NIELSEN (SNI.OL) | 313.50 | -5.86% | 2023-04-03 11:35:10 |
| MKB Nedsense (NEDSE.AS) | 0.12 | -5.74% | 2023-04-03 11:03:40 |
| BASTIDE LE CONFORT (BLC.PA) | 27.75 | -4.97% | 2023-04-03 11:45:15 |
Winners today
1. ASETEK (ASTK.OL)
24.77% Price Change
Asetek A/S, together with its subsidiaries, engages in the designing, developing, and marketing of liquid cooling solutions in Asia, Europe, and the Americas. The company operates through Liquid cooling, Data center and SimSports segments. Its products are used in personal computers, servers, and data centers to provide improved performance, acoustics, and energy efficiency. It serves original equipment manufacturers, resellers, and channel partners. The company was founded in 1997 and is headquartered in Aalborg, Denmark.
Oslo Børs Benchmark Index_GI ended the session with ASETEK jumping 24.77% to €6.90 on Monday while Oslo Børs Benchmark Index_GI rose 1.26% to €1,208.60.
Earnings Per Share
As for profitability, ASETEK has a trailing twelve months EPS of kr4.12.
PE Ratio
ASETEK has a trailing twelve months price to earnings ratio of 1.68. Meaning, the purchaser of the share is investing kr1.68 for every norwegian krone of annual earnings.
Volatility
ASETEK’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.83%, a negative 4.80%, and a positive 3.93%.
ASETEK’s highest amplitude of average volatility was 7.06% (last week), 8.30% (last month), and 3.93% (last quarter).
More news about ASETEK.
2. EXMAR (EXM.BR)
20% Price Change
Exmar NV provides shipping and energy supply chain solutions worldwide. It operates through three segments: Shipping, Infrastructure, and Supporting Services. The company transports liquefied gas products, such as liquid petroleum gas, butane, propane, anhydrous ammonia, and petrochemical gases. It also engages in ownership and leasing of offshore assets; development of drilling and production designs; asset construction; and provision of engineering services related to marine vessels, ships, and offshore units to the marine oil and gas industry. In addition, the company builds, owns, and operates LNG infrastructure comprising floating liquefaction of gas fields, and floating storage and regasification units, as well as provides ship-to-ship transfer services. Further, it provides ship management services, consultancy and engineering, and travel agency services; and manufactures ropes for marine and offshore applications. Additionally, the company designs, builds, installs, and operates floating production, storage, and offloading units; and operates, installs, and maintains contractor, mining companies, drilling contractors, and accommodation barges. Exmar NV was founded in 1829 and is headquartered in Antwerp, Belgium.
BEL 20 ended the session with EXMAR rising 20% to €11.64 on Monday while BEL 20 slid 0.26% to €3,783.43.
Earnings Per Share
As for profitability, EXMAR has a trailing twelve months EPS of €1.06.
PE Ratio
EXMAR has a trailing twelve months price to earnings ratio of 10.99. Meaning, the purchaser of the share is investing €10.99 for every euro of annual earnings.
Volatility
EXMAR’s last week, last month’s, and last quarter’s current intraday variation average was 3.34%, 0.58%, and 1.58%.
EXMAR’s highest amplitude of average volatility was 3.34% (last week), 2.01% (last month), and 1.58% (last quarter).
More news about EXMAR.
3. INNATE PHARMA (IPH.PA)
14.75% Price Change
Innate Pharma S.A., a biotechnology company, discovers, develops, and commercializes therapeutic antibodies for the treatment of oncology indications in France and internationally. The company's products include Lacutamab (IPH4102), an anti-KIR3DL2 antibody, which is in Phase II clinical trials for the treatment of cutaneous T-cell and peripheral T-cell lymphoma, as well as in Phase II clinical trials to treat refractory sézary syndrome; Monalizumab, an immune checkpoint inhibitor that is in Phase III clinical trial to treat advanced solid tumors comprising colorectal and lung cancer, as well as head and neck cancer; Avdoralimab (IPH5401), a monoclonal antibody blocking C5a binding to C5aR1 that is in Phase II clinicals trials for the treatment of COVID-19, bullous pemphigoid, chronic spontaneous urticaria, and other inflammatory diseases; IPH5201, a blocking antibody that is in Phase 1 clinical trials targeting the CD39 immunosuppressive pathway; IPH5301, an anti-CD73 antibody targeting the immunosuppressive adenosine pathway to promote antitumor immunity; and IPH6101, a NKp46-based NK cell engager for the generation and evaluation of up to two bispecific NK cell engagers. Its products in preclinical trials are IPH43, an anti-MICA/B antibody drug conjugate; Anti-Siglec-9, an antibody program; IPH65, a tetraspecific proprietary antibody; IPH25, a checkpoint inhibitor; and IPH62 and IPH64 programs. Innate Pharma S.A. has licensing and collaboration agreements with AstraZeneca, Novo Nordisk A/S, Sanofi, and Orega Biotech; and co-development and license agreement with MedImmune Limited. The company was incorporated in 1999 and is headquartered in Marseille, France.
CAC 40 ended the session with INNATE PHARMA rising 14.75% to €3.08 on Monday, after two sequential sessions in a row of gains. CAC 40 jumped 0.32% to €7,345.96, after five consecutive sessions in a row of gains, on what was a somewhat bullish trend trading session today.
Earnings Per Share
As for profitability, INNATE PHARMA has a trailing twelve months EPS of €-0.811.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, INNATE PHARMA’s stock is considered to be oversold (<=20).
Volatility
INNATE PHARMA’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.53%, a negative 0.28%, and a positive 2.42%.
INNATE PHARMA’s highest amplitude of average volatility was 1.25% (last week), 2.50% (last month), and 2.42% (last quarter).
More news about INNATE PHARMA.
4. DNO (DNO.OL)
14.41% Price Change
DNO ASA engages in the exploration, development, and production of oil and gas assets in the Middle East, the North Sea, and West Africa. Its flagship project is the Tawke field that is located in the Kurdistan region of Iraq. The company was founded in 1971 and is headquartered in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with DNO rising 14.41% to €11.75 on Monday, after four consecutive sessions in a row of gains. Oslo Børs Benchmark Index_GI rose 1.26% to €1,208.60, after five sequential sessions in a row of gains, on what was an all-around bullish trend exchanging session today.
Earnings Per Share
As for profitability, DNO has a trailing twelve months EPS of kr-2.43.
More news about DNO.
5. QUADIENT (QDT.PA)
11.32% Price Change
Quadient S.A. provides business solutions for customers through digital and physical channels in France and internationally. The company offers customer experience management, business process automation, mail-related solutions, and parcel locker solutions. It provides Quadient Inspire, a software solution that helps businesses design, manage, and send personalized, omnichannel communications in large volumes. The company also offers Quadient Impress, a multichannel outbound document management platform; YayPay, account receivable process automation solutions; and Beanworks, accounts payable solution automating error-prone manual processes. In addition, it provides lines of software and hardware for preparing and sending mails in low and high volumes. Further, the company operates a pick-up, drop-off solution that offers businesses and people who need to manage their deliveries and returns. Additionally, it distributes print finishing equipment, such as guillotines, binding machines, laminating machines, and paper folding machines; provides professional and maintenance services; shipping software solutions; and automated packaging solutions. It serves financial services, healthcare, higher education, insurance, public sectors/government, retail, service providers, shipping carriers, telecommunications, and utilities industries. The company was formerly known as Neopost S.A. and changed its name to Quadient S.A. in September 2019. Quadient S.A. was founded in 1924 and is headquartered in Bagneux, France.
CAC 40 ended the session with QUADIENT jumping 11.32% to €18.68 on Monday while CAC 40 jumped 0.32% to €7,345.96.
Earnings Per Share
As for profitability, QUADIENT has a trailing twelve months EPS of €1.8.
PE Ratio
QUADIENT has a trailing twelve months price to earnings ratio of 10.38. Meaning, the purchaser of the share is investing €10.38 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1.31%.
Volatility
QUADIENT’s last week, last month’s, and last quarter’s current intraday variation average was a positive 1.99%, a negative 0.20%, and a positive 1.15%.
QUADIENT’s highest amplitude of average volatility was 1.99% (last week), 1.45% (last month), and 1.15% (last quarter).
Volume
Today’s last reported volume for QUADIENT is 100450 which is 134.01% above its average volume of 42925.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, QUADIENT’s stock is considered to be oversold (<=20).
More news about QUADIENT.
6. QUESTERRE ENERGY (QEC.OL)
11.11% Price Change
Questerre Energy Corporation acquires, explores, and develops non-conventional oil and gas projects in Canada. It produces tight oil, oil shale, shale oil, and shale gas. The company primarily holds 40,960 acres located in Kakwa, west central Alberta, including a 25% working interest in 10,080 acres in Kakwa Central; 50% working interest in 4,480 acres in Kakwa North; 50% interest in 22,400 acres in Kakwa West; and 50% interest in 3,840 acres in Kakwa South. It also holds 100% working interest in 11,035 acres located in Antler, Saskatchewan; and oil shale assets in Jordan. The company was formerly known as Westpro Equipment Ltd. and changed its name to Questerre Energy Corporation in December 2000. The company was incorporated in 1971 and is headquartered in Calgary, Canada.
Oslo Børs Benchmark Index_GI ended the session with QUESTERRE ENERGY rising 11.11% to €2.00 on Monday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI jumped 1.26% to €1,208.60, after five successive sessions in a row of gains, on what was an all-around up trend trading session today.
Earnings Per Share
As for profitability, QUESTERRE ENERGY has a trailing twelve months EPS of kr-1.89.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.96%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, QUESTERRE ENERGY’s stock is considered to be oversold (<=20).
Yearly Top and Bottom Value
QUESTERRE ENERGY’s stock is valued at kr2.00 at 22:40 EST, way under its 52-week high of kr2.53 and way above its 52-week low of kr1.27.
Revenue Growth
Year-on-year quarterly revenue growth grew by 45.5%, now sitting on 46.92M for the twelve trailing months.
Moving Average
QUESTERRE ENERGY’s worth is higher than its 50-day moving average of kr1.83 and way higher than its 200-day moving average of kr1.80.
More news about QUESTERRE ENERGY.
7. ARAMIS GROUP (ARAMI.PA)
9.15% Price Change
Aramis Group SAS engages in the online sale of used cars in Europe. The company operates Aramisauto, Cardoen, and Clicars brands in France, Belgium, and Spain, as well as CarSupermarket platform in the United Kingdom. Aramis Group SAS was founded in 2001 and is based in Arcueil, France.
CAC 40 ended the session with ARAMIS GROUP jumping 9.15% to €3.96 on Monday while CAC 40 rose 0.32% to €7,345.96.
Earnings Per Share
As for profitability, ARAMIS GROUP has a trailing twelve months EPS of €-1.998.
More news about ARAMIS GROUP.
8. FINATIS (FNTS.PA)
7.86% Price Change
Finatis Société Anonyme operates in the food distribution business in France and Latin America. It operates monoprix, franprix, casino supermarkets, petit casinos, casino shops, spars, vivals, géant hypermarkets, etc. The company also distributes sports equipment under the Go Sport brand; and invests in real estate properties, as well as manages a portfolio of private equity investments. The company was incorporated in 1971 and is headquartered in Paris, France. Finatis Société Anonyme is a subsidiary of Euris SAS.
CAC 40 ended the session with FINATIS jumping 7.86% to €7.55 on Monday, following the last session’s upward trend. CAC 40 jumped 0.32% to €7,345.96, after five successive sessions in a row of gains, on what was a somewhat bullish trend exchanging session today.
Earnings Per Share
As for profitability, FINATIS has a trailing twelve months EPS of €-32.99.
More news about FINATIS.
9. SEABIRD EXPLORAT (SBX.OL)
7.14% Price Change
SeaBird Exploration Plc, together with its subsidiaries, provides marine 2D and 3D seismic data for the oil and gas industry in Europe, Africa, the Middle East, North and South America, and the Asia Pacific. The company offers 2D seismic, and 3D and 3D shallow water acquisition services; and source vessels that provide conventional undershoot, 4D repeat survey, wide azimuth, push reverse, long-term charter and vessel management, in-house source modelling and environmental decay analysis, and spot charter services. It also engages in the marine minerals business. The company was founded in 1996 and is based in Nicosia, Cyprus.
Oslo Børs Benchmark Index_GI ended the session with SEABIRD EXPLORAT rising 7.14% to €4.58 on Monday while Oslo Børs Benchmark Index_GI rose 1.26% to €1,208.60.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -30.6%.
Volatility
SEABIRD EXPLORAT’s last week, last month’s, and last quarter’s current intraday variation average was a positive 1.91%, a negative 0.88%, and a positive 3.25%.
SEABIRD EXPLORAT’s highest amplitude of average volatility was 3.27% (last week), 2.71% (last month), and 3.25% (last quarter).
More news about SEABIRD EXPLORAT.
10. FONCIERE 7 INVEST (LEBL.PA)
6.82% Price Change
Foncière 7 investissement Société Anonyme operates as a real estate company. The company is headquartered in Paris, France. Foncière 7 investissement Société Anonyme is a subsidiary of Ingefin SA.
CAC 40 ended the session with FONCIERE 7 INVEST rising 6.82% to €0.94 on Monday while CAC 40 rose 0.32% to €7,345.96.
Earnings Per Share
As for profitability, FONCIERE 7 INVEST has a trailing twelve months EPS of €-0.052.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, FONCIERE 7 INVEST’s stock is considered to be overbought (>=80).
More news about FONCIERE 7 INVEST.
Losers Today
1. SODITECH (SEC.PA)
-17.44% Price Change
Soditech SA engages in the integration of mechanical, thermal, and electronic sub-assemblies in space, research, and defense fields in France. It designs structural sub-assemblies and integrates optical and thermal equipment, such as OSRs, SSMs, heaters, and heat pipes; designs and manufactures multi-layer insulation products; and designs, manufactures, and tests space harnesses on instruments or platforms. The company also provides calculation services, such as static, dynamic, thermal, and thermoelastic; designs assembly tools; and designs and produces super insulating multi-layer mattresses for ultra-vacuum areas. In addition, it develops, qualifies, manufactures, and tests embedded cabinets; and designs, assembles, and tests racks and test equipment racks. The company was formerly known as Soditech Ingenierie SA. Soditech SA was founded in 1990 and is headquartered in Aix-en-Provence, France.
CAC 40 ended the session with SODITECH falling 17.44% to €1.42 on Monday while CAC 40 jumped 0.32% to €7,345.96.
Earnings Per Share
As for profitability, SODITECH has a trailing twelve months EPS of €0.023.
PE Ratio
SODITECH has a trailing twelve months price to earnings ratio of 61.74. Meaning, the purchaser of the share is investing €61.74 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.66%.
More news about SODITECH.
2. CROSSWOOD (CROS.PA)
-11.87% Price Change
Crosswood SA engages in real estate activity in France. Its property portfolio includes shops and offices, and housing properties. The company was formerly known as Desquenne et Giral. Crosswood SA was incorporated in 1935 and is based in Paris, France. Crosswood SA operates as a subsidiary of Compagnie Financiere De Broceliande.
CAC 40 ended the session with CROSSWOOD dropping 11.87% to €7.05 on Monday while CAC 40 jumped 0.32% to €7,345.96.
Earnings Per Share
As for profitability, CROSSWOOD has a trailing twelve months EPS of €0.55.
PE Ratio
CROSSWOOD has a trailing twelve months price to earnings ratio of 12.82. Meaning, the purchaser of the share is investing €12.82 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.48%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 18.5%, now sitting on 1.17M for the twelve trailing months.
Yearly Top and Bottom Value
CROSSWOOD’s stock is valued at €7.05 at 22:40 EST, way under its 52-week high of €8.30 and way above its 52-week low of €4.58.
More news about CROSSWOOD.
3. ABIONYX PHARMA (ABNX.PA)
-8.55% Price Change
ABIONYX Pharma SA, a biotech company, discovers and develops therapies for the treatment of renal and ophthalmological diseases. The company is developing CER-001, a negatively-charged lipoprotein particle which contains human recombinant apoA-I, the natural high density lipoprotein (HDL) protein, and sphingomyelin and dipalmitoylphosphatidylglycerol natural phospholipids designed to mimicks the structural and functional biological properties of pre-beta HDL for the treatment of post-acute coronary syndrome patients and familial primary hypoalphalipoproteinemia patients; CER-002, a peroxisome proliferator-activated receptor delta specific agonist for the treatment of cardiovascular and metabolic diseases; and CER-209, a drug candidate for the treatment of metabolic diseases in the liver, as well as atherosclerois and non-alcoholic steato-hepatitis. It has a strategic partnership with GTP Biologics and VBI Therapeutics Group for the bioproduction of the bio-HDL in France. The company was formerly known as Cerenis Therapeutics Holding SA and changed its name to ABIONYX Pharma SA in August 2019. ABIONYX Pharma SA was founded in 2005 and is based in Balma, France.
CAC 40 ended the session with ABIONYX PHARMA sliding 8.55% to €2.09 on Monday, after three consecutive sessions in a row of gains. CAC 40 jumped 0.32% to €7,345.96, after five sequential sessions in a row of gains, on what was a somewhat up trend trading session today.
Earnings Per Share
As for profitability, ABIONYX PHARMA has a trailing twelve months EPS of €-0.138.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -91.7%.
Yearly Top and Bottom Value
ABIONYX PHARMA’s stock is valued at €2.09 at 22:40 EST, way below its 52-week high of €2.62 and way above its 52-week low of €1.39.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ABIONYX PHARMA’s stock is considered to be oversold (<=20).
Revenue Growth
Year-on-year quarterly revenue growth grew by 9640.7%, now sitting on 3.28M for the twelve trailing months.
More news about ABIONYX PHARMA.
4. OKEANIS ECO TANKER (OET.OL)
-7.96% Price Change
Okeanis Eco Tankers Corp., a tanker company, engages in the ownership, chartering and operation of oil tanker vessels worldwide. The company also provides various shipping services, such as technical support, maintenance, and insurance consulting services. It operates a fleet of six modern scrubber-fitted Suezmax tankers, seven modern scrubber-fitted VLCC tankers, and a VLCC tanker. The company was incorporated in 2018 and is based in Piraeus, Greece.
Oslo Børs Benchmark Index_GI ended the session with OKEANIS ECO TANKER dropping 7.96% to €237.00 on Monday while Oslo Børs Benchmark Index_GI rose 1.26% to €1,208.60.
Earnings Per Share
As for profitability, OKEANIS ECO TANKER has a trailing twelve months EPS of kr-2.17.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21.67%.
Volatility
OKEANIS ECO TANKER’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.33%, a negative 0.11%, and a positive 2.50%.
OKEANIS ECO TANKER’s highest amplitude of average volatility was 2.01% (last week), 2.50% (last month), and 2.50% (last quarter).
Yearly Top and Bottom Value
OKEANIS ECO TANKER’s stock is valued at kr237.00 at 22:40 EST, way below its 52-week high of kr275.50 and way above its 52-week low of kr82.90.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, OKEANIS ECO TANKER’s stock is considered to be overbought (>=80).
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 2944.3% and 255.4%, respectively.
More news about OKEANIS ECO TANKER.
5. AKVA GROUP (AKVA.OL)
-7.48% Price Change
AKVA group ASA designs, purchases, manufactures, assembles, sells, and installs technology products; and provides rental and consulting services for the aquaculture industry. The company operates through three segments: Sea Based Technology (SBT), Digital, and Land Based Technology. The SBT segment offers plastic cages, steel cages, fish farming cages, feed barges, feed systems, sensor and camera systems, light systems, net cleaning systems, remotely operating vehicles, and nets and mooring systems under the Polarcirkel, Wavemaster, and Akvasmart hardware brands. This segment also supplies polyethylene boats and pipes to aquaculture and other industries, as well as plastic pen. The Digital segment provides production control, planning, traceability, and ERP software for the aquaculture and fishing industries under the Fishtalk, AKVAconnect, and AKVA Observe. The Land Based Technology segment designs and delivers recirculation systems for land-based fish farming, as well as provides water quality conditions for fresh and seawater operations. AKVA group ASA operates in Norway, Chile, the United Kingdom, Denmark, Canada, and internationally. The company was incorporated in 1982 and is based in Klepp Stasjon, Norway. AKVA group ASA is a subsidiary of Egersund Group AS.
Oslo Børs Benchmark Index_GI ended the session with AKVA GROUP dropping 7.48% to €54.40 on Monday while Oslo Børs Benchmark Index_GI rose 1.26% to €1,208.60.
Earnings Per Share
As for profitability, AKVA GROUP has a trailing twelve months EPS of kr2.74.
PE Ratio
AKVA GROUP has a trailing twelve months price to earnings ratio of 19.87. Meaning, the purchaser of the share is investing kr19.87 for every norwegian krone of annual earnings.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, AKVA GROUP’s stock is considered to be overbought (>=80).
More news about AKVA GROUP.
6. FRONTLINE (FRO.OL)
-6.81% Price Change
Frontline Ltd., a shipping company, engages in the seaborne transportation of crude oil and oil products worldwide. It owns and operates oil and product tankers. As of December 31, 2021, the company operated a fleet of 70 vessels. It is also involved in the charter, purchase, and sale of vessels. The company was founded in 1985 and is based in Hamilton, Bermuda.
Oslo Børs Benchmark Index_GI ended the session with FRONTLINE falling 6.81% to €159.56 on Monday, after two successive sessions in a row of gains. Oslo Børs Benchmark Index_GI jumped 1.26% to €1,208.60, after five sequential sessions in a row of gains, on what was an all-around bullish trend exchanging session today.
Earnings Per Share
As for profitability, FRONTLINE has a trailing twelve months EPS of kr17.33.
PE Ratio
FRONTLINE has a trailing twelve months price to earnings ratio of 9.21. Meaning, the purchaser of the share is investing kr9.21 for every norwegian krone of annual earnings.
Volatility
FRONTLINE’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.45%, a negative 0.61%, and a positive 2.55%.
FRONTLINE’s highest amplitude of average volatility was 1.30% (last week), 2.05% (last month), and 2.55% (last quarter).
Volume
Today’s last reported volume for FRONTLINE is 1378590 which is 21.7% above its average volume of 1132730.
More news about FRONTLINE.
7. ADUX (ADUX.PA)
-5.88% Price Change
AdUX SA provides advertising services in France, Belgium, Italy, Spain, the Netherlands, and internationally. It provides non-intrusive advertising, in-content advertising, brand content, and geomarketing services. AdUX SA was founded in 1996 and is headquartered in Paris, France.
CAC 40 ended the session with ADUX sliding 5.88% to €1.44 on Monday, after two consecutive sessions in a row of gains. CAC 40 rose 0.32% to €7,345.96, after five consecutive sessions in a row of gains, on what was a somewhat up trend exchanging session today.
Earnings Per Share
As for profitability, ADUX has a trailing twelve months EPS of €-0.14.
Volatility
ADUX’s last week, last month’s, and last quarter’s current intraday variation average was 0.18%, 0.27%, and 2.35%.
ADUX’s highest amplitude of average volatility was 1.83% (last week), 1.56% (last month), and 2.35% (last quarter).
More news about ADUX.
8. STOLT-NIELSEN (SNI.OL)
-5.86% Price Change
Stolt-Nielsen Limited provides transportation, storage, and distribution solutions for bulk liquid chemicals, edible oils, acids, and other specialty liquids worldwide. It operates through five segments: Tankers, Terminals, Tank Containers, Stolt Sea Farm, and Stolt-Nielsen Gas. The company also produces, processes, and markets seafood, including turbot and sole; and transports, stores, and distributes chemicals, clean petroleum products, liquefied petroleum gases, vegetable oils, biofuels, and oleochemicals, as well as alternative fuels and feedstocks. In addition, it owns and operates liquid natural gas carriers. The company was founded in 1959 and is based in London, the United Kingdom. Stolt-Nielsen Limited is a subsidiary of Fiducia Ltd.
Oslo Børs Benchmark Index_GI ended the session with STOLT-NIELSEN dropping 5.86% to €313.50 on Monday while Oslo Børs Benchmark Index_GI jumped 1.26% to €1,208.60.
Earnings Per Share
As for profitability, STOLT-NIELSEN has a trailing twelve months EPS of kr6.73.
PE Ratio
STOLT-NIELSEN has a trailing twelve months price to earnings ratio of 46.6. Meaning, the purchaser of the share is investing kr46.6 for every norwegian krone of annual earnings.
Yearly Top and Bottom Value
STOLT-NIELSEN’s stock is valued at kr313.50 at 22:40 EST, under its 52-week high of kr346.50 and way higher than its 52-week low of kr155.60.
Earnings Before Interest, Taxes, Depreciation, and Amortization
STOLT-NIELSEN’s EBITDA is 199.43.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Apr 25, 2023, the estimated forward annual dividend rate is 25.91 and the estimated forward annual dividend yield is 7.55%.
Moving Average
STOLT-NIELSEN’s worth is above its 50-day moving average of kr302.70 and way above its 200-day moving average of kr250.96.
More news about STOLT-NIELSEN.
9. MKB Nedsense (NEDSE.AS)
-5.74% Price Change
MKB Nedsense N.V. engages in the finance and lending of money to natural persons and legal entities. It also provides guarantees and/or other securities towards third parties for its obligations and/or for obligations for companies in the investment portfolio. The company was formerly known as Nedsense Enterprises N.V. MKB Nedsense N.V. was founded in 1999 and is based in Bussum, the Netherlands.
AEX-Index ended the session with MKB Nedsense dropping 5.74% to €0.12 on Monday, after two consecutive sessions in a row of losses. AEX-Index jumped 0.29% to €758.41, after three successive sessions in a row of gains, on what was a somewhat up trend exchanging session today.
Earnings Per Share
As for profitability, MKB Nedsense has a trailing twelve months EPS of €0.005.
PE Ratio
MKB Nedsense has a trailing twelve months price to earnings ratio of 23. Meaning, the purchaser of the share is investing €23 for every euro of annual earnings.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, MKB Nedsense’s stock is considered to be overbought (>=80).
Volatility
MKB Nedsense’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.19%, a negative 0.88%, and a positive 3.59%.
MKB Nedsense’s highest amplitude of average volatility was 4.30% (last week), 4.02% (last month), and 3.59% (last quarter).
More news about MKB Nedsense.
10. BASTIDE LE CONFORT (BLC.PA)
-4.97% Price Change
Bastide Le Confort Médical SA engages in the sale and rental of medical equipment for individuals and health professionals in France and internationally. The company provides medical materials, such as lift chairs, bathroom medical equipment, medical measuring devices, pillows, sitting posture aids, senior electrostimulation devices, shoes, food supplements, first aid products, shopping trolleys, telephones, cranksets, pressotherapy devices, technical help, overbed tables, medical rooms, sleep apnea devices, electric scooters, wheelchairs, walkers and rollators, and walking sticks; and wellness accessories comprising circulatory stimulators, revivals, relaxation massage gel, essential oils, and pedicure and foot care products. It also offers incontinence products, including full change adults, anatomical protections, urinary protections, traversable straight protections, disposable pads, onesie and sleep suits, hygiene and body care products, and swimsuits, as well as absorbent, support, and net briefs; and home care services for elderly, sick, and disabled. Bastide Le Confort Médical SA was founded in 1977 and is headquartered in Caissargues, France.
CAC 40 ended the session with BASTIDE LE CONFORT sliding 4.97% to €27.75 on Monday while CAC 40 rose 0.32% to €7,345.96.
Earnings Per Share
As for profitability, BASTIDE LE CONFORT has a trailing twelve months EPS of €1.94.
PE Ratio
BASTIDE LE CONFORT has a trailing twelve months price to earnings ratio of 14.3. Meaning, the purchaser of the share is investing €14.3 for every euro of annual earnings.
Yearly Top and Bottom Value
BASTIDE LE CONFORT’s stock is valued at €27.75 at 22:40 EST, way under its 52-week high of €40.50 and way above its 52-week low of €24.45.
Volume
Today’s last reported volume for BASTIDE LE CONFORT is 9602 which is 80.42% above its average volume of 5322.
More news about BASTIDE LE CONFORT.
Stay up to date with our winners and losers daily report
